What we are seeing in the market.
Operator analysis of health markets in Europe, the US, and MENA: four monthly Vital Signs editions, the PROGNOSIS flagship, perspectives, and the reference work behind them.
Operator analysis of health markets in Europe, the US, and MENA: four monthly Vital Signs editions, the PROGNOSIS flagship, perspectives, and the reference work behind them.
Vital Signs · MedTech
A device can wait about two years between its first approval and its second, and the lead piece sets out what stretched the longest waits. This month's deals show what buyers paid for medtech companies, from $240 million to $2.1 billion, and what Stryker's $400 million in CMR Surgical buys it.
27 October 2026
Vital Signs · AI HealthcareThe FDA authorised two AI devices their makers may keep changing, and Medicare found no benefit category for a cleared device, so it pays nothing for it.
Vital Signs · AI HealthcareThe EU moved the AI Act deadline for AI in medical devices to August 2028, but three obligation sets kept their original dates and are in force today.